Search research articles
Contact Us
Filters
Showing results (81-90 of 163) with videos related to
Page
of 17
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 2009
Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression
Andrea Paradisi, Carine Maisse, Marie-May Coissieux, et al.
Bulletin Du Cancer
|
December 17, 2016
Immunotherapy and patients treated for cancer with microsatellite instability
Raphaël Colle, Romain Cohen, Delphine Cochereau, et al.
Journal of the National Cancer Institute
|
April 16, 2020
Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer
Kaysia Ludford, Romain Cohen, Magali Svrcek, et al.
Cancer Treatment Reviews
|
December 26, 2021
A comprehensive overview of tumour deposits in colorectal cancer: Towards a next TNM classification
Jean-François Delattre, Ayse Selcen Oguz Erdogan, Romain Cohen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 13, 2019
Mismatch Repair System Deficiency Is Associated With Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
Nicolas Meillan, Dewi Vernerey, Jérémie H Lefèvre, et al.
Cancer Treatment Reviews
|
February 11, 2025
How do I treat dMMR/MSI gastro-oesophageal adenocarcinoma in 2025? A position paper from the EORTC-GITCG gastro-esophageal task force
Christelle de la Fouchardière, Antonella Cammarota, Magali Svrcek, et al.
Neuroendocrinology
|
September 4, 2015
Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors
Jerome Cros, Emilie Moati, Jerome Raffenne, et al.
Journal of the National Cancer Institute
|
October 7, 2010
Azathioprine-induced carcinogenesis in mice according to Msh2 genotype
Alexandra Chalastanis, Virginie Penard-Lacronique, Magali Svrcek, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 7, 2014
ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma
Anais Laforest, Thomas Aparicio, Aziz Zaanan, et al.
The Oncologist
|
April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
Raphael Colle, Sara Lonardi, Marine Cachanado, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 163) with videos related to
Sort By:
Page
of 17
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 2009
Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression
Andrea Paradisi, Carine Maisse, Marie-May Coissieux, et al.
Bulletin Du Cancer
|
December 17, 2016
Immunotherapy and patients treated for cancer with microsatellite instability
Raphaël Colle, Romain Cohen, Delphine Cochereau, et al.
Journal of the National Cancer Institute
|
April 16, 2020
Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer
Kaysia Ludford, Romain Cohen, Magali Svrcek, et al.
Cancer Treatment Reviews
|
December 26, 2021
A comprehensive overview of tumour deposits in colorectal cancer: Towards a next TNM classification
Jean-François Delattre, Ayse Selcen Oguz Erdogan, Romain Cohen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 13, 2019
Mismatch Repair System Deficiency Is Associated With Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
Nicolas Meillan, Dewi Vernerey, Jérémie H Lefèvre, et al.
Cancer Treatment Reviews
|
February 11, 2025
How do I treat dMMR/MSI gastro-oesophageal adenocarcinoma in 2025? A position paper from the EORTC-GITCG gastro-esophageal task force
Christelle de la Fouchardière, Antonella Cammarota, Magali Svrcek, et al.
Neuroendocrinology
|
September 4, 2015
Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors
Jerome Cros, Emilie Moati, Jerome Raffenne, et al.
Journal of the National Cancer Institute
|
October 7, 2010
Azathioprine-induced carcinogenesis in mice according to Msh2 genotype
Alexandra Chalastanis, Virginie Penard-Lacronique, Magali Svrcek, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 7, 2014
ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma
Anais Laforest, Thomas Aparicio, Aziz Zaanan, et al.
The Oncologist
|
April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
Raphael Colle, Sara Lonardi, Marine Cachanado, et al.
Page
of 17